Concepedia

Author

Christoph Schubart

Friedrich-Alexander-Universität Erlangen-NürnbergORCID

Also Known As

Christoph Schubart

24

Publications

275

Citations

10

H-Index

20

Concepts

All Affiliations

Friedrich-Alexander-Universität Erlangen-NürnbergUniversitätsklinikum ErlangenComprehensive Cancer Center ErlangenUniversitätsklinikum WürzburgComprehensive Cancer Center Mainfranken
CS

About

Christoph Schubart is an author at Friedrich-Alexander-Universität Erlangen-Nürnberg specializing in medicine, tumor biology, and cancer research.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

66

2

Cell Biology

2

2

41

3

Public Health

1

1

25

4

Biostatistics

1

1

25

5

Health Policy

1

1

25

Christoph Schubart

×

11

Publications

260

Citations

10

H-Index

YearCitations

RELMα-expressing macrophages protect against fatal lung damage and reduce parasite burden during helminth infection

Branislav Krljanac, Christoph Schubart, Ronald Naumann,

Science Immunology

2019

57

MET Amplification in Non-Small Cell Lung Cancer (NSCLC)—A Consecutive Evaluation Using Next-Generation Sequencing (NGS) in a Real-World Setting

Christoph Schubart, Robert Stöhr, Lars Tögel,

Cancers

2021

40

Selective expression of constitutively activated STAT6 in intestinal epithelial cells promotes differentiation of secretory cells and protection against helminths

Christoph Schubart, Branislav Krljanac, Manuel Otte,

Mucosal Immunology

2018

26

Identification of Disparities in Personalized Cancer Care—A Joint Approach of the German WERA Consortium

Florian Lüke, Florian Haller, Kirsten Utpatel,

Cancers

2022

25

Gene fusions are frequent in ACTH-secreting neuroendocrine neoplasms of the pancreas, but not in their non-pancreatic counterparts

Abbas Agaimy, Atsuko Kasajima, Robert Stoehr,

Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin

2023

24

Small cell transformation in EGFR-mutated non-small cell lung cancer: DLL3 expression and efficacy of immune checkpoint inhibitors or tyrosine kinase inhibitors combined with chemotherapy

Felix Carl Saalfeld, Petros Christopoulos, Carina Wenzel,

European Journal of Cancer

2024

18

IL-4 and helminth infection downregulate MINCLE-dependent macrophage response to mycobacteria and Th17 adjuvanticity

Judith Schick, Meltem Altunay, Matthew Lacorcia,

eLife

2023

17

Recurrent EWSR1::COLCA2 Fusions Define a Novel Sarcoma With Spindle/Round Cell Morphology and Strong Predilection for the Sinonasal Tract

Abbas Agaimy, Martina Baněčková, John R. de Almeida,

The American Journal of Surgical Pathology

2022

15

TFE3‐rearranged nonmelanotic renal PEComa: a case series expanding their phenotypic and fusion landscape

Abbas Agaimy, Andrés Acosta, Liang Cheng,

Histopathology

2024

15

Determinants Affecting the Clinical Implementation of a Molecularly Informed Molecular Tumor Board Recommendation: Experience from a Tertiary Cancer Center

Lars Tögel, Christoph Schubart, Sebastian Lettmaier,

Cancers

2023

13

Page 1